🌿 Allergy season isn’t just spring anymore, it can last year-round. Featured in Haute, Purvi Parikh, MD, a spokesperson with Allergy & Asthma Network shares expert tips to stay ahead: start meds early, limit exposure & explore long-term options like immunotherapy. hauteliving.com/hautebeauty/...

We extend a warm welcome to, Apogee Therapeutics, as the newest member of the Allergy & Asthma Network Corporate Council. Collaborations with our corporate partners are essential for developing patient-centered treatments, improving clinical trial design, and advancing our mission.

Podcast episode alert! 🎧 If antihistamines aren't helping your chronic hives, there's a new treatment option to know about. Kortney and Dr. Gupta are breaking down the REMIX trial, which looked at remibrutinib, a pill that works differently from antihistamines.

Eli Lilly recently shared updates about Ebglyss, a biologic therapy targeting interleukin-13 (IL-13), a key driver of type 2 inflammation in atopic dermatitis.

#Sponsored Does your toddler have a peanut allergy? Learn about a clinical study of a skin patch for the treatment of peanut allergy. If your child has or may have a peanut allergy, we ask you to consider the COMFORT Toddlers study. It may help us learn more about treating peanut allergy.

Chronic Rhinosinusitis with Nasal Polyps is a long-term inflammatory condition that can lead to persistent sinus symptoms like congestion, facial pressure, sinus pain, and reduced sense of smell which can significantly impacting daily functioning and quality of life.

This past weekend, we were proud to present Allergy & Asthma Network research at the American Academy of Allergy, Asthma & Immunology (AAAAI) 2026 Annual Conference highlighting two important themes in patient-centered care:

Who is ready for a GREAT @aaaaiorg.bsky.social 2026 conference? @allergyasthmahq.bsky.social is! We are stocked at booth #1513 with free resources including BRAND NEW infant anaphylaxis symptom guides - English and Spanish! Don’t miss your chance to grab a copy! #AAAAI2026

Can you imagine a world without smell? For people living with anosmia, this is their reality every day. Today marks #AnosmiaAwarenessDay and we are shining a light on the loss of smell, a symptom that can have a major impact on quality of life.

Sanofi - Regeneron has announced that Dupixent (dupilumab) has been approved in the U.S. for allergic fungal rhinosinusitis (AFRS) in adults and children ages 6+ with a history of sinonasal surgery. It is the first therapy specifically approved for this condition.

Congratulations to Kaléo on 25 years of dedication to advancing medication delivery and patient safety. Allergy & Asthma Network is proud to partner with Kaléo on anaphylaxis education and promoting its AUVI-Q epinephrine auto-injector.

New episode 🎧 Kortney and Dr, Gupta joined by Dr. Cherie Zachary, President of American College of Allergy, Asthma and Immunology (ACAAI), to talk about the future of allergy care. Dr. Zachary shares her story as both a patient with allergic disease and a doctor.

Allergy & Asthma Network has issued a statement opposing the U.S. EPA’s repeal of the 2009 Endangerment Finding, citing serious concerns about the public health impact for people living with asthma, allergies, and related respiratory conditions.

Does your toddler have a peanut allergy? Learn about a clinical study of a skin patch for the treatment of peanut allergy. If your child has or may have a peanut allergy, we ask you to consider the COMFORT Toddlers study. It may help us learn more about treating peanut allergy in toddlers.

The FDA has issued a Complete Response Letter for Aquestive Therapeutics' Anaphylm™, a sublingual epinephrine film under review for the treatment of severe allergic reactions.

Allergy & Asthma Network applauds Congress for approving funding to reinstate the National Asthma Control Program (NACP) through the Consolidated Appropriations Act of 2026. This is a critical win for people living with asthma.

Angel’s journey begins in El Paso, Texas, where living with solar urticaria, a rare form of chronic hives triggered by sun exposure, means that even brief time outdoors can lead to painful reactions.

🎙️ Latest episode of The Itch Review is breaking down the research behind the Peds-AIRQ. #DYK a child can be told their asthma is “controlled” and still be at high risk for an asthma attack? 🤯 That’s because many asthma tools only ask about symptoms. And symptoms don’t always tell the full story.

It's winter, which means eye allergy symptoms may be taking over your day. Let’s stop and ask ourselves, what treatments are available for eye allergy symptoms? Eye allergies, or allergic conjunctivitis, are often triggered by pollen, pet dander, mold, and other airborne allergens.

In a recent Healio Q&A, Allergy & Asthma Network’s Director of Advocacy, Nissa Shaffi, explains how restoring funding for the National Asthma Control Program could strengthen prevention efforts, support state and community programs, and reduce asthma-related emergency visits.

Ever ask yourself, what is the link between weight and #asthma? Board-certified allergist and immunologist William Anderson, MD, explains that obesity-related asthma is a unique form of asthma where excess weight and inflammation can worsen symptoms and make treatment less effective.

Sanofi shared new study results for an investigational biologic medication called amlitelimab, which is being studied for people ages 12 and older with moderate-to-severe eczema (atopic dermatitis).

✨ Emmeka’s journey with chronic hives wasn’t just physical…it was emotional, invisible, & isolating at times. From unpredictable flare-ups to doctors who couldn’t always see what she was feeling, she learned to advocate fiercely for herself, adjust her routines, and redefine beauty on her own terms.

🚀 We’re kicking off the Patient Advocacy Leadership Initiative (PALI)! Join us on Feb. 18th for a special informational session where you’ll learn how PALI empowers patients, families, and community members to become confident advocates for asthma, allergies, and related conditions.

Snow on your mind? It's on the mind of many across the United States today. ❄️ Cold, dry air can be tough on your lungs if you have asthma.and can trigger coughing, wheezing, or shortness of breath. If you’re heading outside to shovel, play, or commute, protect your breathing:

🚀 We’re kicking off the Patient Advocacy Leadership Initiative (PALI)! Join us on Feb. 18th for a special informational session where you’ll learn how PALI empowers patients, families, and community members to become confident advocates for asthma, allergies, and related conditions.

Cold air is a well-known #asthma trigger, particularly during winter months and outdoor physical activity. Simple preventive strategies can significantly reduce risk. Seasonal education remains a key part of asthma self-management. allergyasthmanetwork.org/news/cold-ai...

💛 For years, Rachell lived with chronic hives while feeling dismissed, misunderstood, and unheard as a Hispanic woman. Appointments left her with more questions than solutions. But she kept advocating for herself until she found a doctor who truly listened.

Allergy & Asthma Network applauds the U.S. House and Senate for proposing $33.5 million in FY 2026 funding for the Centers for Disease Control and Prevention’s National Asthma Control Program (NACP).

We are celebrating the signing of the Protecting Children with Food Allergies Act into law! This effort was led by Sen. Richard Durbin and U.S. Senator Deb Fischer. Thank you to both! This legislation takes a meaningful step toward improving student safety by requiring food allergy training

Following our final 2025 outreach event in North Carolina, we’re reflecting on the impact of this incredible journey of the Trusted Messengers program and the community that made it possible. Together, we are building a healthier future!

You are your own best advocate when living with #ChronicUrticaria. Bring these 3 questions to your next appointment: 1️⃣ What’s causing my hives? 2️⃣ What treatment options are available? 3️⃣ How will we track my progress?

We’re proud to have Nanette Perez as a patient advocate with Allergy & Asthma Network & grateful for her willingness to share her journey to help others feel seen & supported. Stories like hers remind us why patient voices matter & why listening leads to better care, understanding, & support.

Some children can outgrow #foodallergies but it depends on the child and the allergen. Board-certified allergist Leena Padhye, MD, explains how allergists test for outgrown allergies using blood tests and oral food challenges done under medical supervision in this Ask the Allergist video.

Wondering why your skin reacts differently? Genetics, environmental factors, & access to care play a role in how eczema shows up on skin of color. Allergy & Asthma Network & ACAAI's Eczema in Skin of Color site offers trusted resources to help you see & manage it better.  EczemaInSkinOfColor.org

A fresh year means a fresh chance to prioritize your health, especially your asthma. 🌬️ Review your meds, update your action plan, track your triggers, and step confidently into 2026 with support from Allergy & Asthma Network.

Happy Holidays from the Allergy & Asthma Network ❄️☃️ Just a friendly reminder that even snowmen need healthy lungs. Sending warm wishes, cool vibes, and lots of holiday cheer from our team to you! 💙🫁🌟🎄

Allergy & Asthma Network’s Director of Advocacy Nissa Shaffi joined an Epinephrine Access panel discussion hosted by the Duke-Margolis Institute for Health Policy and the U.S. Food and Drug Administration (FDA) on Dec. 16.

For 40 years, the Allergy & Asthma Network has been connecting people to life-changing resources, support, and hope. As we celebrate this milestone, our Director of Public Health Engagement, Tori Martel, shares a heartfelt thank you to the sponsors who stand with us.

This study is investigating the investigational drug solrikitug for its safety and effective treatment of asthma in adults. Qualifying participants will be enrolled at a study site, where healthcare professionals will oversee administration of either the study drug or a placebo. #Sponsored #Uniquity

The U.S. Food and Drug Administration (FDA) has approved GSK’s Exdensur (depemokimab-ulaa) as a new biologic add-on maintenance treatment for people aged 12 and older with severe asthma with an eosinophilic phenotype.

40 𝐲𝐞𝐚𝐫𝐬 𝐨𝐟 𝐚𝐝𝐯𝐨𝐜𝐚𝐜𝐲.40 𝐲𝐞𝐚𝐫𝐬 𝐨𝐟 𝐩𝐚𝐭𝐢𝐞𝐧𝐭 𝐯𝐨𝐢𝐜𝐞𝐬 𝐝𝐫𝐢𝐯𝐢𝐧𝐠 𝐜𝐡𝐚𝐧𝐠𝐞. From protecting students’ rights to carry life-saving asthma & allergy medications in all 50 states, to advancing clean air standards, vaccine access, & affordable care, advocacy has always been at the heart of Allergy & Asthma Network.

New Episode! What does the KIT D816V mutation have to do with anaphylaxis? Dr. Gupta and Kortney are breaking down the PROSPECTOR trial. A study that looked to see if you can detect the KIT D816V mutation using a blood test in people who had anaphylaxis.

💔 "My stepdaughter Arya* died from an asthma attack. I want to do something to educate the public because I don't believe most people know that asthma can actually be fatal." For 40 years, we've been working to prevent tragedies like this. Our Virtual Asthma Coaching helps families recognize

Have you ever stopped and wondered why new asthma treatment guidelines recommend quick-relief inhalers with two medicines instead of just one?

🧴 Corticosteroids help relieve eczema but long-term use has risks. A survey completed by Allergy & Asthma Network & International Topical Steroid Awareness Network found many people living with #eczema used topical or oral #corticosteroids for years.

Think #allergies take a break in winter? ❄️ Think again! Indoor allergens can trigger symptoms like sneezing, itchy eyes, congestion, or even #asthma flares. 🤧🏠 Learn how to find relief: allergyasthmanetwork.org/news/winter-allergies-causes-symptoms/ #WinterAllergies

#NationalInfluenzaVaccinationWeek is this week and it’s not too late to get your flu shot! 🩹 Protect yourself and loved ones this winter, especially if you have asthma or other chronic conditions. Together, we can #FightFlu. Learn more: allergyasthmanetwork.org/news/why-get... #FluShot

💙 Thank you for making #GivingTuesday 2025 incredible! Your support helps us continue 40 years of building bridges where others see barriers. Thanks to all those who donated, empowering continued work connecting underserved communities to specialized resources and life-changing support!

🍁 As we gather with family and friends this Thanksgiving, remember to keep the air clean for everyone, especially loved ones with asthma. 🚭 Exposure to secondhand smoke or vaping can inflame the airways, weaken the lungs, and trigger asthma attacks. Even incense and scented candles can pose risks.